AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2024

Oct 24, 2024

30587_dirs_2024-10-23_6bec3e0b-96e0-42da-8d23-d09a0916a39a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2024-10-21

Reporting Person: MOMTAZEE JAMES C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-21	Common Shares	A	1231	—	Acquired	93665	Direct

Footnotes

F1: Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date.